A New Nasdaq Arrival With More Than a New Name
Biotechnology companies often arrive on Wall Street with an ambitious presentation and a conspicuously modest bank account. Mentari Therapeutics (Nasdaq: MTRI) has chosen a more substantial entrance. The Waltham, Massachusetts-based migraine-drug developer…